• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强 MRI 序列测量肝脏观察大小的比较及其对 LI-RADS 分类的影响。

Comparison of gadoxetate disodium-enhanced MRI sequences for measuring hepatic observation size and its implication of LI-RADS classification.

机构信息

Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.

Department of Radiology, Kangdong Seong-Sim Hospital, Hallym University College of Medicine, Seoul, South Korea.

出版信息

Abdom Radiol (NY). 2022 Mar;47(3):1024-1031. doi: 10.1007/s00261-021-03403-2. Epub 2022 Jan 12.

DOI:10.1007/s00261-021-03403-2
PMID:35020008
Abstract

PURPOSE

We aimed to determine the optimal image sequence for measurement of hepatic observations on gadoxetate disodium-enhanced MRI in comparison with pathologic measurement, and to evaluate its clinical impact on the Liver Imaging Reporting and Data System (LI-RADS) v2018 classification.

METHODS

Two hundred and fifty-three patients (279 hepatic observations) who underwent gadoxetate disodium-enhanced MRI and subsequent hepatectomy were retrospectively included. Two radiologists independently evaluated the visualization score (five-point scale) and size of each observation on six MRI sequences (T1-weighted, T2-weighted, arterial-phase, portal venous-phase, transitional-phase [TP], and hepatobiliary-phase [HBP] images) and assigned a LI-RADS category. Correlations between MRI and pathologic measurements were evaluated using Pearson correlation coefficients. A repeated measures analysis of variance with Bonferroni post hoc comparison tests was used to compare the visualization scores and absolute differences between MRI sequences and pathologic measurements. The LI-RADS classification according the size measurement of each MRI sequence was compared using Cochran's Q test with a post hoc McNemar's test.

RESULTS

Of the MRI sequences, HBP had the highest visualization score (4.1 ± 0.6) and correlation coefficient (r = 0.965). The absolute difference between MRI and pathologic measurement was lowest on TP (2.3 mm ± 2.2), followed by HBP (2.4 mm ± 2.1). In the LI-RADS classifications, HBP did not have any non-visible observations. Regarding LR-3, LR-4, and LR-5, there was no significantly different LI-RADS classification among the six MRI sequences (p ≥ 0.122).

CONCLUSION

Hepatobiliary-phase images are clinically useful for measuring hepatic observations on gadoxetate disodium-enhanced MRI, especially regarding visibility and correlation with pathologic findings.

摘要

目的

本研究旨在确定钆塞酸二钠增强 MRI 上肝脏观察的最佳图像序列,以与病理测量进行比较,并评估其对肝脏影像报告和数据系统(LI-RADS)v2018 分类的临床影响。

方法

回顾性纳入 253 例(279 个肝脏观察)接受钆塞酸二钠增强 MRI 检查并随后接受肝切除术的患者。两位放射科医生分别对六组 MRI 序列(T1 加权像、T2 加权像、动脉期、门静脉期、过渡期 [TP] 和肝胆期 [HBP] 图像)上的每个观察进行可视化评分(五分制)和大小评估,并对 LI-RADS 类别进行赋值。采用 Pearson 相关系数评估 MRI 与病理测量之间的相关性。采用重复测量方差分析和 Bonferroni 事后比较检验比较 MRI 序列与病理测量之间的可视化评分和绝对差异。采用 Cochran's Q 检验和事后 McNemar 检验比较各 MRI 序列大小测量的 LI-RADS 分类。

结果

在 MRI 序列中,HBP 的可视化评分(4.1±0.6)和相关系数(r=0.965)最高。TP(2.3mm±2.2)的 MRI 与病理测量的绝对差值最小,其次是 HBP(2.4mm±2.1)。在 LI-RADS 分类中,HBP 没有不可见的观察。在 LR-3、LR-4 和 LR-5 中,六组 MRI 序列之间的 LI-RADS 分类无显著差异(p≥0.122)。

结论

肝胆期图像对测量钆塞酸二钠增强 MRI 上的肝脏观察具有临床意义,特别是在可见性和与病理发现的相关性方面。

相似文献

1
Comparison of gadoxetate disodium-enhanced MRI sequences for measuring hepatic observation size and its implication of LI-RADS classification.钆塞酸二钠增强 MRI 序列测量肝脏观察大小的比较及其对 LI-RADS 分类的影响。
Abdom Radiol (NY). 2022 Mar;47(3):1024-1031. doi: 10.1007/s00261-021-03403-2. Epub 2022 Jan 12.
2
LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.LI-RADS 版本 2017 与版本 2018:钆塞酸二钠增强 MRI 诊断肝细胞癌。
Radiology. 2019 Sep;292(3):655-663. doi: 10.1148/radiol.2019182867. Epub 2019 Jul 16.
3
Modifying LI-RADS on Gadoxetate Disodium-Enhanced MRI: A Secondary Analysis of a Prospective Observational Study.在钆塞酸二钠增强 MRI 上修改 LI-RADS:一项前瞻性观察研究的二次分析。
J Magn Reson Imaging. 2022 Aug;56(2):399-412. doi: 10.1002/jmri.28056. Epub 2022 Jan 7.
4
Data-Driven Modification of the LI-RADS Major Feature System on Gadoxetate Disodium-Enhanced MRI: Toward Better Sensitivity and Simplicity.基于钆塞酸二钠增强MRI的LI-RADS主要特征系统的数据驱动修改:追求更高的敏感性和更简化。
J Magn Reson Imaging. 2022 Feb;55(2):493-506. doi: 10.1002/jmri.27824. Epub 2021 Jul 8.
5
Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma.钆塞酸增强 MRI 的动脉减影图像提高了早期肝细胞癌的诊断准确性。
J Hepatol. 2019 Sep;71(3):534-542. doi: 10.1016/j.jhep.2019.05.005. Epub 2019 May 18.
6
The role of lesion hypointensity on gadobenate dimeglumine-enhanced hepatobiliary phase MRI as an additional major imaging feature for HCC classification using LI-RADS v2018 criteria.钆贝葡胺增强肝胆期 MRI 病变低信号强度在 LI-RADS v2018 标准中作为 HCC 分类的另一个主要影像学特征的作用。
Eur Radiol. 2021 Oct;31(10):7715-7724. doi: 10.1007/s00330-021-07807-y. Epub 2021 Mar 29.
7
Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.前瞻性应用肝脏成像报告和数据系统(LI-RADS)在钆塞酸增强 MRI 中的诊断准确性。
Eur Radiol. 2018 May;28(5):2038-2046. doi: 10.1007/s00330-017-5188-y. Epub 2017 Dec 11.
8
Liver imaging reporting and data system diagnostic performance in hepatocellular carcinoma when modifying the definition of "washout" on gadoxetic acid-enhanced magnetic resonance imaging.钆塞酸增强磁共振成像中修改“洗脱”定义时肝成像报告和数据系统在肝细胞癌中的诊断性能。
Arab J Gastroenterol. 2024 Feb;25(1):58-63. doi: 10.1016/j.ajg.2023.12.012. Epub 2024 Jan 20.
9
Comparison of Gadobenate-Enhanced MRI and Gadoxetate-Enhanced MRI for Hepatocellular Carcinoma Detection Using LI-RADS Version 2018: A Prospective Intraindividual Randomized Study.使用2018版肝脏影像报告和数据系统(LI-RADS)比较钆贝葡胺增强MRI与钆塞酸二钠增强MRI对肝细胞癌的检测:一项前瞻性个体内随机研究
AJR Am J Roentgenol. 2022 Apr;218(4):687-698. doi: 10.2214/AJR.21.26818. Epub 2021 Nov 24.
10
Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS.采用扩散加权成像的细胞外对比增强 MRI 对 HCC 诊断的前瞻性比较:与使用 LI-RADS 的钆塞酸对比剂的比较。
Eur Radiol. 2020 Jul;30(7):3723-3734. doi: 10.1007/s00330-020-06753-5. Epub 2020 Mar 3.

引用本文的文献

1
Simplified liver imaging reporting and data system for the diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging.用于钆塞酸二钠增强磁共振成像诊断肝细胞癌的简化肝脏影像报告和数据系统
World J Gastrointest Oncol. 2024 Jun 15;16(6):2439-2448. doi: 10.4251/wjgo.v16.i6.2439.
2
LI-RADS threshold growth based on tumor growth rate can improve the diagnosis of hepatocellular carcinoma ≤ 3.0 cm.基于肿瘤生长率的LI-RADS阈值增长可改善对≤3.0厘米肝细胞癌的诊断。
Eur Radiol. 2024 Feb;34(2):1210-1218. doi: 10.1007/s00330-023-10092-6. Epub 2023 Aug 17.

本文引用的文献

1
Statistics corner: A guide to appropriate use of correlation coefficient in medical research.统计专栏:医学研究中相关系数合理应用指南
Malawi Med J. 2012 Sep;24(3):69-71.